WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (NASDAQ:BMET) announced today that in connection with its offering of notes to repay in full its unsecured bridge facilities, the Company is providing the following preliminary unaudited financial information for the three months ended August 31, 2007.
The Company’s estimated net sales for the three months ended August 31, 2007 were in the range of $550 million to $555 million, approximately an 8% to 9% increase over net sales of $508 million for the three months ended August 31, 2006, due principally to growth in the Company’s worldwide reconstructive products, primarily hips, knees and dental implants. Excluding the impact of sales of instruments (which the Company discontinued selling to distributors in the United States in the third quarter of fiscal 2007), estimated net sales increased by approximately 10% for the three months ended August 31, 2007 compared to the same period in 2006. Estimated Adjusted EBITDA for the quarter was in the range of $190 million to $195 million, approximately a 6% to 8% increase over Adjusted EBITDA of $180 million for the three months ended August 31, 2006.
